Jane Street’s Inozyme Pharma INZY Stock Holding History

Jane Street’s Portfolio INZY Stock Details INZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-55,766	Closed	-$223K	–	11253
2025 Q2	$223K	Buy	+55,766	New	+$138K	﹤0.01%	8369
2024 Q4	–	Sell	-49,460	Closed	-$259K	–	9974
2024 Q3	$259K	Buy	49,460 +3,443	+7%	+$17.9K	﹤0.01%	8268
2024 Q2	$205K	Buy	46,017 +16,932	+58%	+$82.1K	﹤0.01%	8344
2024 Q1	$223K	Sell	29,085 -22,319	-43%	-$122K	﹤0.01%	8030
2023 Q4	$219K	Buy	+51,404	New	+$183K	﹤0.01%	8082
2023 Q2	–	Sell	-53,525	Closed	-$307K	–	9110
2023 Q1	$307K	Buy	+53,525	New	+$141K	﹤0.01%	7165

Jane Street's INZY Position: Q3 2025 in Review

Jane Street sold out of Inozyme Pharma (INZY) in Q3 2025, closing a stake of 55,766 shares — an estimated $223K sold.

Jane Street first reported a position in INZY in Q1 2023 and held it in 6 quarters. The position peaked at $307K in Q1 2023. 0 funds tracked by Wall St. Rank hold INZY as of Q3 2025.

Jane Street reported no remaining Inozyme Pharma position as of Q3 2025 after selling out during the quarter.
Jane Street sold 55,766 Inozyme Pharma shares in Q3 2025, an estimated $223K.
Jane Street first reported a position in Inozyme Pharma in Q1 2023 and held it in 6 quarters.
Jane Street's Inozyme Pharma position peaked at $307K in Q1 2023.
0 funds tracked by Wall St. Rank held Inozyme Pharma as of Q3 2025.

Based on Jane Street's 13F filing for Q3 2025, filed 14 Nov 2025.